Latest News and Press Releases
NINER Pharmaceutical Strengthens Global Presence with Strategic IV Fluid Supply Initiative for the U.S. and Latin American Markets
November 15, 2024 01:09 ET
|
NINER Pharmaceutical LLC
DUBAI, United Arab Emirates, Nov. 15, 2024 (GLOBE NEWSWIRE) -- NINER Pharmaceutical, a leading name in the pharmaceutical sector, announces its strategic expansion into the U.S. and Latin American...
1win and David Warner Launch Charitable #1win1000hits Challenge
November 15, 2024 01:00 ET
|
1win
1win and David Warner unite for a charitable cause.Everyone can join #1win1000hits by sharing their reels on Instagram.1win donate to charitable organizations early in 2025. WILLEMSTAD, Curaçao,...
Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio
November 15, 2024 01:00 ET
|
Sandoz Group
MEDIA RELEASE Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One of several biosimilar value drivers for...
Start of Day Message
November 15, 2024 01:00 ET
|
GlobeNewswire, Inc.
LONDON, 15 Nov. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
Aegon trading update for third quarter 2024
November 15, 2024 01:00 ET
|
Aegon Ltd.
The Hague, November 15, 2024 - Please click here to access all 3Q 2024 trading update related documents. EUR 336 million operating capital generation, before holding funding and operating...
Richemont's 2024 Interim Report now available online
November 15, 2024 01:00 ET
|
Compagnie Financière Richemont SA
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR 15 NOVEMBER 2024 RICHEMONT’S 2024 INTERIM REPORT NOW AVAILABLE ONLINE Richemont announces the publication of its interim report and...
Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
November 15, 2024 01:00 ET
|
Sanofi - Aventis Groupe
Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive...
Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
November 15, 2024 00:59 ET
|
Regeneron Pharmaceuticals, Inc.
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by...
Mowi ASA: Ex-dividend NOK 1.50 today
November 15, 2024 00:30 ET
|
Mowi ASA
The shares in Mowi ASA will be traded ex-dividend of NOK 1.50 as from today 15 November 2024. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian...
Okeanis Eco Tankers Corp. – Ex Dividend Date
November 15, 2024 00:00 ET
|
Okeanis Eco Tankers Corp
ATHENS, Greece, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Reference is made to the key information relating to Q3 2024 dividend announced by Okeanis Eco Tankers Corp. ("OET" or the "Company") (NYSE: ECO /...
- November 14, 2024 23:55 ET Americans Want to Recycle but Worry About Getting It Right
- November 14, 2024 23:47 ET Colonel Sanders Serves Up a One-of-a Kind Combo for the Eras